PSYCHOTROPIC PHARMACOGENOMIC TESTING: EFFECTS ON PROVIDER PRESCRIBING PATTERNS AND PHQ-9 DEPRESSION SCREENING SCORES IN A RURAL MICHIGAN FAMILY PRACTICE